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Abstract
Background: Community-based screening for TB, combined with HIV and syphilis testing, faces a number of
barriers. One significant barrier is the value that target communities place on such screening.
Methods: Integrated testing for TB, HIV, and syphilis was performed in neighborhoods identified using geographic
information systems-based disease mapping. TB testing included skin testing and interferon gamma release assays.
Subjects completed a survey describing disease risk factors, healthcare access, healthcare utilization, and willingness
to pay for integrated testing.
Results: Behavioral and social risk factors among the 113 subjects were prevalent (71% prior incarceration, 27%
prior or current crack cocaine use, 35% homelessness), and only 38% had a regular healthcare provider. The initial
24 subjects reported that they would be willing to pay a median $20 (IQR: 0-100) for HIV testing and $10 (IQR: 0-
100) for TB testing when the question was asked in an open-ended fashion, but when the question was changed
to a multiple-choice format, the next 89 subjects reported that they would pay a median $5 for testing, and 23%
reported that they would either not pay anything to get tested or would need to be paid $5 to get tested for TB,
HIV, or syphilis. Among persons who received tuberculin skin testing, only 14/78 (18%) participants returned to
have their skin tests read. Only 14/109 (13%) persons who underwent HIV testing returned to receive their HIV
results.
Conclusion: The relatively high-risk persons screened in this community outreach study placed low value on
testing. Reported willingness to pay for such testing, while low, likely overestimated the true willingness to pay.
Successful TB, HIV, and syphilis integrated testing programs in high risk populations will likely require one-visit
diagnostic testing and incentives.
Background
While targeted testing of high-risk groups for latent
tuberculosis infection (LTBI) has long been a priority
set forth by the Centers for Disease Control and Preven-
tion [1], LTBI testing has not traditionally been part of
community-based HIV outreach programs [2]. Several
barriers to community-based integrated screenings
incorporating tuberculosis (TB), human immunodefi-
ciency virus (HIV), and sexually transmitted diseases
(STDs) exist. Aside from administrative separation of
TB, HIV and STD control programs in state and county
health departments, perhaps the most significant chal-
lenge to incorporating TB testing has been the two-visit
process of the tuberculin skin test (TST), requiring par-
ticipants to return to the community site for interpreta-
tion [3]. Follow-up rates for TST have been reported as
low as 33% in studies of TB community outreach initia-
tives [3-5] and have even been problematic when a
“mandatory” approach is used: A study in Oregon
restricted access to shelters, soup kitchens, detoxifica-
tion programs, and transitional housing and programs
based on participation in TB screening, but still sug-
gested that homeless persons shifting their place of
sleep posed a barrier to follow-up [6].
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persons at highest risk for TB, HIV, and STDs are
socioeconomically disadvantaged and either do not have
adequate resources to pay for screening or choose not
to use their limited resources for such screening. In a
survey of 248 symptomatic persons with active tubercu-
losis in Los Angeles, delay in seeking care was asso-
ciated with concern about cost [7]. Concern about cost
has similarly been demonstrated as a barrier to HIV
testing [8].
Furthermore, persons in low-TB incidence settings
often have limited knowledge regarding TB, particularly
regarding risk reduction measures [9,10]. However,
populations targeted for HIV screening do express inter-
est in tuberculosis screening. In a survey of 292 home-
less shelter residents in San Francisco, subjects were
generally knowledgeable about TB, 57.8% expressed con-
cern about contracting TB infection, and 47.1%
described willingness to take measures to avoid TB
transmission [11]. We aimed to characterize community
acceptance and willingness to pay for and participate in
LTBI screening as part of a larger geographic informa-
tion systems (GIS)-based community outreach inte-
grated screening study.
Methods
In the context of a larger GIS-based study, residences of
individuals diagnosed with TB disease, HIV, and syphilis
1/1/05-12/31/07 in Wake County, North Carolina were
mapped using ArcMap 9.3 GIS software, with the areas
of highest densities of all three diseases (defined as areas
with greater than ten cases per square mile over the
three-year period) designated as “hot spots.” Am a po f
Wake County streets was overlaid on the study map to
determine which street intersections and local businesses
were within the “hot spots.” In collaboration with nurses
and disease intervention specialists from the HIV, syphi-
lis, and TB clinics at Wake County Human Services in
North Carolina, we identified sites for local screenings.
Sites were chosen based on location within a “hot spot,”
availability of an area within the site to administer confi-
dential surveys, and acceptability by the site owner/man-
ager. Community-based advertising and small incentives
(snacks, beverage and a $5 grocery gift card) were used
to attract participants. At each screening event, written
informed consent was obtained from each participant.
Participants were asked questions regarding medical and
epidemiologic TB risk, behaviors, willingness to pay, and
health care utilization. After the interview, participants
received HIV, syphilis, and LTBI testing. Participants
were asked to come to the health department evening
clinic for HIV results, and in cases of positive HIV or
syphilis results, participants were also contacted directly
by a county disease intervention specialist.
In the initial group of patients enrolled in the study
(N = 78), two tests for LTBI were performed. Blood was
drawn for the Quantiferon Gold In-Tube (QFT-GIT)
(Cellestis Limited, Carnegie, Victoria, Australia) assay,
an interferon gamma release assay (IGRA) for latent TB.
A TST was subsequently placed by the Mantoux
method, and persons were asked to return to the same
community site or the health department TB Clinic in
48-72 hours for TST interpretation. After an interim
analysis (N = 24), the written questionnaire was modi-
fied for the remainder of participants (N = 89) due to
concern about reliability of responses (see Results).
Patient responses were analyzed with descriptive sta-
tistics using SAS software (Cary, NC). The study was
approved by the Duke University Medical Center Insti-
tutional Review Board and the Wake County Human
Rights Consumer Affairs/Human Research Committee.
QFT-GIT assays were performed according to manufac-
turer’s instructions, and HIV and syphilis tests were per-
formed according to routine health department
protocols.
Results
A total of 113 participants were recruited through ele-
ven community outreach screenings conducted at six
different sites, including a church, a night club, several
community centers, and an apartment complex. Of the
participants, 54% were male, the majority were African
American (90%) and U.S. born (92%), and mean age was
41.4 ± 12.6 (Table 1). The study group represented a
population at high-risk for LTBI and STDs, with 71%
reporting prior incarceration, 27% reporting current or
prior cocaine use, and 35% reporting current or prior
homelessness. Furthermore, 53% of persons admitted to
unprotected sex within the past year and 49% reported a
prior STD. Most subjects (62%) did not have a regular
healthcare provider.
The initial 24 subjects enrolled stated they would be
willing to pay a median of $20 to get tested for HIV and
$10 to get tested for TB (Table 2). After a data quality
review, the open-ended questions were removed from
the questionnaire because some participants were
responding with amounts of money beyond a reasonable
range. For example, one participant stated he would pay
“two million dollars” for TB and HIV testing. When the
survey was modified from open-ended questions (Q1,
Q2) to multiple choice (Q4) for the remaining 89 parti-
cipants, 23% said they would not pay any amount for
testing.
At these high-risk community sites, there was also a
slight preference for receiving a tuberculosis blood test
over skin test (39% vs. 23%), with more persons trusting
the blood test to give the “right answer” versus the skin
test (47% vs. 9%, p < 0.001). Participants reported they
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(IQR): 0,20) to get their preferred TB test (skin test or
blood test). When asked whether they would be (theore-
tically) willing to give up the free study-provided snack
in exchange for testing, 38 (84%) participants agreed
that they would give up a free snack for their preferred
test.
Seventy-eight persons had a TST placed. For the
remainder of participants enrolled in the study (N = 35),
TST was omitted from the screening procedure due to
poor follow-up in the initial group. Of the total 113 par-
ticipants, there were four phlebotomy failures and five
indeterminate QFT-GIT
® results, so 109 persons had
valid HIV tests obtained and 104/113 (92%) of persons
had valid QFT-GIT
® results. Of the 109 persons who
had blood drawn for HIV testing, 14 (13%) presented to
the health department to receive their HIV results. Simi-
larly, while 89% (98/110 who responded to the question)
of participants reported that it would be easy to return
to the same site in 2-3 days for TST interpretation, only
14/78 (18%) of participants actually returned for an
interpretation. Potential barriers to follow-up for the
TST interpretation and HIV result notification visits
were reported relatively infrequently, with only 38%
reporting full-time employment, 19% reporting children
at home, and 40% reporting difficulty with transporta-
tion. When asked about perceived risk to get sick with
TB, 83/106 (78%) thought their risk was low, and 81/
106 (76%) thought their risk to get sick with HIV or
syphilis was low.
Results for participants’ HIV, latent TB, and syphilis
tests were not available at the time of this study, as
this data was being collected as part of a larger geo-
graphic-based integrated screening study. All of the
screenings, however, were performed in two identified
“hot spots": the first in the northern part of the county
with an average case density of all three diseases of
15.7 cases per square mile, and a second in the central
part of the county with an average case density of 19.2
cases per square mile. The remainder of the county
had an average case density of less than 10 cases per
square mile.
Discussion
As tuberculosis control efforts move closer to elimina-
tion in low-incidence countries, LTBI treatment in rela-
tively high-risk but low-healthcare access populations
will become more important to achieve reductions in
incident tuberculosis. Community-based screenings may
be a reasonable strategy to target such populations, but
significant challenges must be overcome to make such
screenings feasible and cost-effective. Our study high-
lights two such challenges: 1) the value that participants
place on receiving these screening tests and 2) low
return rates for tuberculin skin test readings and HIV
result notifications. Our subjects, who reported a num-
ber of risk factors for TB exposure as well as for pro-
gression to TB disease, perceive their risk of TB to be
low. While the test results of specific subjects in this
study were not available for analysis, the case density of
all three diseases (based on public health surveillance) in
our participants’ neighborhoods was higher than other
parts of the county. Participants in this study also
reported relatively low healthcare utilization. The survey
responses suggesting that healthcare is a relatively low
priority in this population were supported by the low
Table 1 Demographics and Behaviors in Participants of
an HIV/syphilis/TB screening (N = 113)
Characteristic N (%)
Male 61 (54.0)
Race/ethnicity
Black, non-Hispanic 101 (90.2)
White, non-Hispanic 9 (8.0)
Hispanic 2 (1.8)
Mean age (standard deviation) 41.4 (12.6)
Foreign-born 9 (8.0)
Previous treatment for active or latent TB (self-reported) 12 (10.6)
Previous HIV test (self-reported) 69 (61.1)
Frequency of alcohol use
None 37 (33.3)
< 1 drink/day 25 (22.5)
1-2 drinks/day 15 (13.5)
> 3 drinks/day 22 (19.8)
> 5 drinks on any day (binge) 12 (10.8)
Tobacco Use
None 18 (16.4)
Former 8 (7.3)
Current 84 (76.4)
Prior incarceration 79 (70.5)
Current or prior intravenous drug use 8 (7.1)
Current or prior crack use 30 (26.5)
Unprotected sex in past year 58 (52.7)
Prior sexually transmitted disease 51 (49.0)
Current or prior homelessness 40 (35.4)
Perceived risk of HIV/syphilis
Low 81 (71.7)
Medium 17 (15.0)
High 8 (7.1)
Not reported 7 (6.2)
Perceived risk of tuberculosis
Low 83 (73.5)
Medium 12 (10.6)
High 11 (9.7)
Not reported 7 (6.2)
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Survey Question Median or N (IQR
or %)
Q1. If testing were not being provided for free today, how much would you be willing to pay to know whether you had
HIV? (N = 24)
$20 (0-100)
Q2. If testing were not being provided for free today, how much would you be willing to pay to know whether you had
syphilis? (N = 24)
$20 (0-50)
Q3. If testing were not being provided for free today, how much would you be willing to pay to know whether you were
infected with the TB germ? (N = 24)
$10 (0-100)
Q4. Would you have come today to get screened for TB, HIV, and syphilis if you had to pay the following amounts (mark the
highest amount, with -1 referring to giving out $1 gift cards)? (N = 88)
-5 2 (2.3)
-1 0 (0)
0 18 (20.5)
1 15 (17.1)
5 53 (60.2)
Q5. How do you feel about getting a skin test (having some liquid injected underneath your skin, like what is done for a TB
skin test)? (N = 113)
Don’t mind at all 91 (81.3)
Somewhat unpleasant 14 (12.5)
Hate it 7 (6.3)
Q6. How do you feel about having blood drawn? (N = 113)
Don’t mind at all 79 (69.9)
Somewhat unpleasant 19 (16.8)
Hate it 15 (13.3)
Q7. How difficult is it for you to return in 2-3 days to have your skin test read? (N = 110)
Easy 98 (89.1)
Somewhat hard 8 (7.3)
Hard 4 (3.6)
Q8. Do you prefer a skin test or blood test? (N = 110)
Skin test 25 (22.7)
Blood test 43 (39.1)
Doesn’t matter 42 (38.2)
Q9. How much would you be willing to pay to get the test that you prefer (instead of the other test)? (N = 113) $5 (0-20)
Q10. Would you give up your snack to get your preferred test? (N = 45)
Yes 38 (84.4)
No 7 (15.6)
Q11. Skin testing requires a second visit 2-3 days after the first. How much is it worth to you to avoid that second visit? ($)
(N = 113)
$0 (0-5)
Q12. How much time does it take for you to get here from where you would normally be on a weekday (work, home, etc.)?
(minutes) (N = 113)
5 (2-20)
Q13. How much time does it take for you to get to the health department from where you would normally be on a
weekday (work, home, etc.)? (minutes) (N = 113)
25 (15-40)
Q14. Usually, how difficult is it for you to get transportation for medical appointments? (N = 110)
Easy 66 (60.0)
Somewhat Hard 21 (19.1)
Hard 23 (20.9)
Q15. Are you working outside the home right now? (N = 110)
Yes 42 (38.2)
No 68 (61.8)
Q16. Do you have children under the age of 18 living with you? (N = 110)
Yes 21 (19.1)
No 89 (80.9)
Q17. Do you have a regular doctor? (N = 110)
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of HIV test results.
While almost all participants expressed a commitment
to return for TST interpretation on initial surveys, most
did not return for interpretation of tests actually placed
in the study, with no clear logistical barriers. Therefore,
the only way to effectively reach this at-risk population
m a yb et h r o u g hi n n o v a t i v ec o m m u n i t yo u t r e a c hp r o -
grams. With participant preference for a blood-based
test that would also eliminate a return visit for interpre-
tation, IGRAs would likely be well-utilized in this kind
of community-based outreach effort, and feasibility and
acceptability of such tests has been demonstrated [12].
Incentivizing community health workers responsible for
connecting LTBI patients with health infrastructure, and
using non-incentive based strategies to engage patients
in care, such as cellular phone text messaging, are other
potential ways to improve patient adherence.
Incentives have enjoyed moderate success in increas-
ing adherence to TB therapy in high-risk populations.
In a randomized control trial of homeless persons with
LTBI, usual care at a TB clinic was compared to com-
munity follow-up with a $5 incentive; completion of
isoniazid therapy was significantly higher in the mone-
tary incentive arm [13]. In a California study of LTBI
treatment in drug users, therapy completion rate was
53% when active outreach was used with a financial
incentive of $5 per visit, compared to 4% when active
outreach was used alone (p < 0.0001) [14]. Likewise, in
a Haitian study of 60 patients with active TB, one
group received free medical care alone, while the sec-
ond group also received financial aid for three months,
travel expenses, nutritional supplements, and monthly
clinic reminders [15]. By one year of follow-up, all of
the patients in the financially-supported group were
cured of their TB, compared to only 57% of patients in
the control group. Consistent with these studies, our
data support a higher likelihood of participation in TB
and STD testing offered in the community with a
monetary incentive rather than free medical care alone
i nac o u n t yc l i n i c .
Conclusion
TB elimination in developed countries will require crea-
tive interventions in disadvantaged populations who do
not access healthcare regularly and may not place a
financial priority on preventive care. TB screening
efforts in such populations should employ blood-based
methodologies that can simultaneously screen for TB,
HIV, and syphilis with a monetary incentive to enhance
patient participation.
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Table 2 Preferences and Willingness to Pay in Participants of an HIV/syphilis/TB screening (N = 113) (Continued)
Yes 42 (38.2)
No 68 (61.8)
Q18. If you do have a regular doctor, when was your last appointment? (N = 42)
Within the past 3 months 27 (64.3)
3 months to 1 year ago 8 (19.1)
More than 1 year ago 6 (14.3)
Don’t remember 1 (2.4)
Q19. Which test do you trust more to give the “right answer"? (N = 107)
Skin test 10 (9.4)
Blood test 50 (46.7)
Doesn’t matter 47 (43.9)
Q20. Would you give up your snack to know your result in a few minutes? (N = 86)
Yes 78 (90.7)
No 8 (9.3)
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